The story of Viagra, and its developer copyright, presents a challenging case study for investors. Initially a blockbuster drug, generating billions in revenue , its exclusivity period created a deluge of lower-priced alternatives , significantly impacting its market share . While specific firms may try to capitalize on similar conditions , the exi